#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Angiosarcoma Anti-HLA antibody test positive Transitional cell cancer of the renal pelvis and ureter Scedosporium infection Head and neck cancer Scleroderma associated digital ulcer Malignant central nervous system neoplasm Malignant oligodendroglioma ABO haemolytic disease of newborn Li-Fraumeni syndrome Hereditary angioedema with C1 esterase inhibitor deficiency Cortical dysplasia Oesophageal atresia Myelin oligodendrocyte glycoprotein antibody-associated disease IgA nephropathy More trials…

Learn about Rare Diseases

Bronchopulmonary dysplasia – Life with Disease Turner’s syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis Myelodysplastic syndrome – Trials in Disease Alagille syndrome – Basic Information Krabbe’s disease – Basic Information Rhabdomyosarcoma recurrent Erdheim-Chester disease – Basic Information Marfan’s syndrome – Diagnostics Cystic fibrosis – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Pegenzileukin Desloratadine Isis 678354 Sodium Salt Gentamicin Sulfate Human Fibrinogen Elasomeran NALMEFENE HYDROCHLORIDE Aripiprazole Terbinafine Egl-001 Nebivolol Fingolimod Hydrochloride Cefuroxime Axetil Crd-4730 VX-407 Feladilimab Phentermine Exenatide Vanzacaftor Ads-010 More therapies…

Learn about Your Condition

Adrenocortical carcinoma Mast cell activation syndrome Oesophageal food impaction VEXAS syndrome Lung adenocarcinoma stage III Craniosynostosis Pyelonephritis Short-bowel syndrome Breast neoplasm Dermatitis Myeloproliferative neoplasm Tubulointerstitial nephritis Naevoid melanoma Neurogenic bladder Vertigo More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Vitiligo

Study on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo

Not recruiting

3 1 1
Investigated Diseases:
- Vitiligo
Investigated Drugs:
- Dexamethasone
Study on the Effects of Ruxolitinib Cream for Patients with Genital Vitiligo

Not recruiting

2 1 1
Investigated Diseases:
- Vitiligo
Investigated Drugs:
- Ruxolitinib
Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo

Not recruiting

2 1
Investigated Drugs:
- Mk-6194
Study on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo

Not recruiting

3 1 1
Investigated Diseases:
- Vitiligo
Investigated Drugs:
- Dexamethasone

1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Vitiligo

Study on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo

Study on the Effects of Ruxolitinib Cream for Patients with Genital Vitiligo

Study on MK-6194 for Treating Adults with Non-Segmental Vitiligo

Study on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies